Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis

Detalhes bibliográficos
Autor(a) principal: Li,Min
Data de Publicação: 2022
Outros Autores: Zhu,Wen-Ye, Wang,Ji, Yang,Xiao-Dong, Li,Wei-Min, Wang,Gang
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Jornal Brasileiro de Pneumologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000101201
Resumo: ABSTRACT Objective: VEGF-D is a potential biomarker for lymphangioleiomyomatosis (LAM); however, its diagnostic performance has yet to be systematically studied. Methods: We searched PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library to identify primary studies on VEGF-D in relation to the diagnosis of LAM. The quality of the studies was evaluated using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Summary estimates of diagnostic accuracy were pooled using a bivariate random effects model. Subgroup and sensitivity analyses were performed to explore possible heterogeneity. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was applied to rate the quality of evidence and indicate the strength of recommendations. Results: Ten studies involving 945 patients were of high risk in quality, as assessed using the QUADAS-2. The pooled diagnostic parameters were indicated as follows: sensitivity = 0.82 (95% CI, 0.71-0.90); specificity = 0.98 (95% CI, 0.94-0.99); and diagnostic OR = 197 (95% CI, 66-587). The AUC of summary ROC analysis was 0.98. The subgroup and sensitivity analyses revealed that the overall performance was not substantially affected by the composition of the control group, prespecified cutoff value, the country of origin, or different cutoff values (p > 0.05 for all). A strong recommendation for serum VEGF-D determination to aid in the diagnosis of LAM was made according to the GRADE. Conclusions: VEGF-D seems to have great potential implications for the diagnosis of LAM in clinical practice due to its excellent specificity and suboptimal sensitivity.
id SBPT-1_2cea8d07016b966819157d3da2903e3e
oai_identifier_str oai:scielo:S1806-37132022000101201
network_acronym_str SBPT-1
network_name_str Jornal Brasileiro de Pneumologia (Online)
repository_id_str
spelling Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysisLymphangioleiomyomatosis/diagnosisVascular endothelial growth factor DBiomarkersMeta-analysisABSTRACT Objective: VEGF-D is a potential biomarker for lymphangioleiomyomatosis (LAM); however, its diagnostic performance has yet to be systematically studied. Methods: We searched PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library to identify primary studies on VEGF-D in relation to the diagnosis of LAM. The quality of the studies was evaluated using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Summary estimates of diagnostic accuracy were pooled using a bivariate random effects model. Subgroup and sensitivity analyses were performed to explore possible heterogeneity. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was applied to rate the quality of evidence and indicate the strength of recommendations. Results: Ten studies involving 945 patients were of high risk in quality, as assessed using the QUADAS-2. The pooled diagnostic parameters were indicated as follows: sensitivity = 0.82 (95% CI, 0.71-0.90); specificity = 0.98 (95% CI, 0.94-0.99); and diagnostic OR = 197 (95% CI, 66-587). The AUC of summary ROC analysis was 0.98. The subgroup and sensitivity analyses revealed that the overall performance was not substantially affected by the composition of the control group, prespecified cutoff value, the country of origin, or different cutoff values (p > 0.05 for all). A strong recommendation for serum VEGF-D determination to aid in the diagnosis of LAM was made according to the GRADE. Conclusions: VEGF-D seems to have great potential implications for the diagnosis of LAM in clinical practice due to its excellent specificity and suboptimal sensitivity.Sociedade Brasileira de Pneumologia e Tisiologia2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000101201Jornal Brasileiro de Pneumologia v.48 n.1 2022reponame:Jornal Brasileiro de Pneumologia (Online)instname:Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)instacron:SBPT10.36416/1806-3756/e20210337info:eu-repo/semantics/openAccessLi,MinZhu,Wen-YeWang,JiYang,Xiao-DongLi,Wei-MinWang,Gangeng2022-03-10T00:00:00Zoai:scielo:S1806-37132022000101201Revistahttp://www.jornaldepneumologia.com.br/default.aspONGhttps://old.scielo.br/oai/scielo-oai.php||jbp@jbp.org.br|| jpneumo@jornaldepneumologia.com.br1806-37561806-3713opendoar:2022-03-10T00:00Jornal Brasileiro de Pneumologia (Online) - Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)false
dc.title.none.fl_str_mv Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
title Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
spellingShingle Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
Li,Min
Lymphangioleiomyomatosis/diagnosis
Vascular endothelial growth factor D
Biomarkers
Meta-analysis
title_short Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
title_full Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
title_fullStr Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
title_full_unstemmed Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
title_sort Diagnostic performance of VEGF-D for lymphangioleiomyomatosis: a meta-analysis
author Li,Min
author_facet Li,Min
Zhu,Wen-Ye
Wang,Ji
Yang,Xiao-Dong
Li,Wei-Min
Wang,Gang
author_role author
author2 Zhu,Wen-Ye
Wang,Ji
Yang,Xiao-Dong
Li,Wei-Min
Wang,Gang
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Li,Min
Zhu,Wen-Ye
Wang,Ji
Yang,Xiao-Dong
Li,Wei-Min
Wang,Gang
dc.subject.por.fl_str_mv Lymphangioleiomyomatosis/diagnosis
Vascular endothelial growth factor D
Biomarkers
Meta-analysis
topic Lymphangioleiomyomatosis/diagnosis
Vascular endothelial growth factor D
Biomarkers
Meta-analysis
description ABSTRACT Objective: VEGF-D is a potential biomarker for lymphangioleiomyomatosis (LAM); however, its diagnostic performance has yet to be systematically studied. Methods: We searched PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library to identify primary studies on VEGF-D in relation to the diagnosis of LAM. The quality of the studies was evaluated using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Summary estimates of diagnostic accuracy were pooled using a bivariate random effects model. Subgroup and sensitivity analyses were performed to explore possible heterogeneity. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) was applied to rate the quality of evidence and indicate the strength of recommendations. Results: Ten studies involving 945 patients were of high risk in quality, as assessed using the QUADAS-2. The pooled diagnostic parameters were indicated as follows: sensitivity = 0.82 (95% CI, 0.71-0.90); specificity = 0.98 (95% CI, 0.94-0.99); and diagnostic OR = 197 (95% CI, 66-587). The AUC of summary ROC analysis was 0.98. The subgroup and sensitivity analyses revealed that the overall performance was not substantially affected by the composition of the control group, prespecified cutoff value, the country of origin, or different cutoff values (p > 0.05 for all). A strong recommendation for serum VEGF-D determination to aid in the diagnosis of LAM was made according to the GRADE. Conclusions: VEGF-D seems to have great potential implications for the diagnosis of LAM in clinical practice due to its excellent specificity and suboptimal sensitivity.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000101201
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132022000101201
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.36416/1806-3756/e20210337
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Pneumologia e Tisiologia
publisher.none.fl_str_mv Sociedade Brasileira de Pneumologia e Tisiologia
dc.source.none.fl_str_mv Jornal Brasileiro de Pneumologia v.48 n.1 2022
reponame:Jornal Brasileiro de Pneumologia (Online)
instname:Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron:SBPT
instname_str Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron_str SBPT
institution SBPT
reponame_str Jornal Brasileiro de Pneumologia (Online)
collection Jornal Brasileiro de Pneumologia (Online)
repository.name.fl_str_mv Jornal Brasileiro de Pneumologia (Online) - Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
repository.mail.fl_str_mv ||jbp@jbp.org.br|| jpneumo@jornaldepneumologia.com.br
_version_ 1750318348243042304